Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA.
² Department of Pharmacy Services, City of Hope National Medical Center, Duarte, California, USA.
³ Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California, USA.
⁴ Department of Quality, Risk and Regulatory Management, City of Hope National Medical Center, Duarte, California, USA.
⁵ Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.

Editorial

Alfredo G Puing et al. J Infect Dis. 2022.

. 2022 Jan 18;225(2):352-354.

doi: 10.1093/infdis/jiab406.

¹ Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte, California, USA.
² Department of Pharmacy Services, City of Hope National Medical Center, Duarte, California, USA.
³ Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California, USA.
⁴ Department of Quality, Risk and Regulatory Management, City of Hope National Medical Center, Duarte, California, USA.
⁵ Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.

No abstract available

Comment in

Reply to Puing et al.
Ganesh R, Philpot LM, Bierle DM, Razonable RR. Ganesh R, et al. J Infect Dis. 2022 Jan 18;225(2):353-355. doi: 10.1093/infdis/jiab407. J Infect Dis. 2022. PMID: 34379766 Free PMC article. No abstract available.

Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
Ganesh R, Philpot LM, Bierle DM, Anderson RJ, Arndt LL, Arndt RF, Culbertson TL, Destro Borgen MJ, Hanson SN, Kennedy BD, Kottke BB, Larsen JJ, Ramar P, Rosedahl JK, Seville MT, Speicher LL, Tulledge-Scheitel SM, Wilker CG, Razonable RR. Ganesh R, et al. J Infect Dis. 2021 Oct 28;224(8):1278-1286. doi: 10.1093/infdis/jiab377. J Infect Dis. 2021. PMID: 34279629 Free PMC article.